M&A Deal Summary

GSK Acquires Block Drug Company

On January 16, 2001, GSK acquired life science company Block Drug Company for 1.2B USD

Acquisition Highlights
  • This is GSK’s 3rd transaction in the Life Science sector.
  • This is GSK’s 11th largest (disclosed) transaction.
  • This is GSK’s 3rd transaction in the United States.
  • This is GSK’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2001-01-16
Target Block Drug Company
Sector Life Science
Buyer(s) GSK
Deal Type Add-on Acquisition
Deal Value 1.2B USD

Target

Block Drug Company

Jersey City, New Jersey, United States
Block Drug Company is a pharmaceutical company specializing in dental care products.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GSK

Brentford, United Kingdom
Category Company
Founded 1715
Sector Life Science
Employees70,212
Revenue 30.3B GBP (2023)
DESCRIPTION
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.

GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.

DEAL STATS #
Overall 4 of 32
Sector (Life Science) 3 of 26
Type (Add-on Acquisition) 2 of 24
State (New Jersey) 1 of 2
Country (United States) 3 of 19
Year (2001) 1 of 1
Size (of disclosed) 11 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2000-01-17 SmithKline Beecham

Brentford, United Kingdom

SmithKline Beecham is a global pharmaceutical company based in Brentford, England.

Buy $75.7B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-07-30 Affymax

Cupertino, California, United States

Affymax is a biopharmaceutical company focused on anemia in kidney disease and cancer. Affymax was established in 2001 and is based in Cupertino, California.

Sell -
Mergr

Product

Company

Legal